BIO-TECHNE Corp (TECH)

↓ Download CSV

CIK 0000842023 · Nasdaq · Biological Products, (No Diagnostic Substances)

  • Sector Manufacturing
  • Incorporated MN
  • Fiscal year ends Jun 30

In fiscal 2026, BIO-TECHNE Corp reported revenue of $1.22B, down 0.4% from the prior year. The company was profitable, with a net margin of 15.0% and a gross margin of 65.8%.

Key ratios (FY2026)

65.8%
Gross margin
20.7%
Operating margin
15.0%
Net margin
8.6%
Return on equity
-0.4%
Revenue growth (YoY)
Metric (FY)2026202520242023202220212020201920182017
Revenue$1.22B$1.22B$1.16B$1.14B$1.11B$931.03M$738.69M$714.01M$642.99M$563.00M
Cost of Revenue$415.97M$429.36M$389.33M$366.89M$349.10M$298.18M$255.50M$240.51M$210.85M$188.46M
Gross Profit$799.07M$790.27M$769.73M$769.82M$756.50M$632.85M$483.19M$473.49M$432.14M$374.54M
Operating Income$251.89M$102.25M$206.69M$298.94M$296.59M$237.30M$157.42M$146.72M$136.18M$120.58M
Net Income$181.86M$73.40M$168.10M$285.44M$263.10M$139.59M$229.30M$96.07M
EPS (Diluted)$1.16$0.46$1.05$1.76$1.66$0.87$5.82$2.47$3.31$2.03
Total Assets$2.59B$2.56B$2.70B$2.64B$2.29B$2.26B$2.03B$1.88B$1.59B$1.56B
Shareholders' Equity$2.11B$1.92B$2.07B$1.97B$1.70B$1.56B$1.38B$1.17B$1.08B$949.63M
Cash & Equivalents$264.71M$162.19M$151.79M$180.57M$172.57M$199.09M$146.62M$100.89M$121.99M$91.61M
Operating Cash Flow$292.07M$287.56M$298.98M$254.39M$325.27M$352.16M$205.22M$181.62M$170.37M$143.72M
Capital Expenditures$28.85M$31.01M$62.88M$38.24M$44.91M$44.30M$51.74M$25.41M$20.93M$15.18M
Shares Outstanding157.01M159.72M160.77M161.85M164.11M161.93M39.40M38.89M38.05M37.50M
Dividends Per Share$0.32$0.32$0.32$0.32$0.32$0.32$1.28$1.28$1.28$1.28